|
|
||||||||
The Annals of Thoracic Surgery, Vol 47, 880-883, Copyright © 1989 by The Society of Thoracic Surgeons
SJ Phillips, C Kongtahworn, RH Zeff, JR Skinner, RS Toon, A Grignon, M Spector and LA Iannone
Of 2,859 patients having percutaneous transluminal coronary angioplasty,
201 (7%) underwent emergency coronary artery bypass grafting. Two
categories of patients were reviewed. Group 1 consisted of 126 patients of
2,304 who had immediate coronary artery bypass grafting after failed
elective percutaneous transluminal coronary angioplasty. Ninety-eight of
these patients had angiographic evidence of occlusion of a coronary artery,
and 28 had angiographic evidence of coronary artery dissection. Epicardial
hemorrhage was observed at operation in 20% (25 patients). Three deaths
(2.4%) occurred in group 1, and an average of 3.3 grafts was performed per
patient. Group 2 comprised 75 of 555 patients who had unsuccessful
attempted percutaneous transluminal coronary angioplasty during an evolving
myocardial infarction and required immediate coronary artery bypass
grafting. Angiography revealed coronary artery occlusion in 61 patients
with dissection in 14. All group 2 patients had evidence of myocardial
injury by electrocardiographic and enzymatic (myocardial-specific isoenzyme
of creatine kinase) criteria. Three deaths (4%) occurred in this group, and
there was an average of 3.4 grafts per patient. Percutaneous transluminal
coronary angioplasty is routinely performed without surgical consultation,
although an operating room and team are usually available. Supportive
techniques include the intraaortic balloon pump and percutaneous
cardiopulmonary bypass. In those patients with coronary artery dissection,
care must be taken to reestablish the true lumen of the coronary artery.
Hemopericardium should be surgically explored and broken guidewires or
other foreign bodies or debris removed. From 1979 through 1986, the number
of patients requiring emergency coronary artery bypass grafting after
percutaneous transluminal coronary angioplasty steadily declined to less
than 5%.
ARTICLES
Disrupted coronary artery caused by angioplasty: supportive and surgical considerations
Department of Cardiovascular Medicine and Surgery, Mercy Hospital Medical Center, Des Moines, Iowa.
This article has been cited by other articles:
![]() |
A. M. Lincoff, L. A. LeNarz, G. J. Despotis, P. K. Smith, J. E. Booth, R. E. Raymond, S. K. Sapp, C. F. Cabot, J. E. Tcheng, R. M. Califf, et al. Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials Ann. Thorac. Surg., August 1, 2000; 70(2): 516 - 526. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |